For the 95% of rare disease patients still without an approved treatment, FDA is working for you. Acting Commissioner Kyle Diamantas shares how FDA is transfor

For the 95% of rare disease patients still without an approved treatment, FDA is working for you. Acting Commissioner Kyle Diamantas shares how FDA is transforming rare disease drug development through the new Rare Disease Framework Initiative. Because every family deserves answers, action, and hop…